Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients

NCT03691493 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03691493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03691493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
February 8, 2019
Completion date
October 13, 2022
Enrollment
36 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, estrogen receptor positive, her2/neu negative, metastatic breast carcinoma, metastatic malignant neoplasm in the bone, progesterone receptor positive, prognostic stage iv breast cancer ajcc v8